Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SAR-444336 by Sanofi for Inflammation: Likelihood of Approval
SAR-444336 is under clinical development by Sanofi and currently in Phase I for Inflammation. According to GlobalData, Phase I drugs...